Biotechnology
Around the world, there is a great deal of interest in the use of biotechnology to develop better varieties of maize.  GM maize now accounts for a large proportion of production in both North and South America.  Use of GM maize is also becoming more common in Eastern countries such as China.

Within the EU, the only country with significant commercial plantings of GM maize is Spain, although experiments have been undertaken elsewhere.  GM maize is attractive to farmers because it can be resistant to an insect called the European Corn Borer. This pest can both decimate grain yields and reduce the quality and usefulness of the remaining grain.

However, it is clear that a significant proportion of EU consumers are unwilling to consume products derived from GM maize.  Consequently Euromaisiers members have stringent quality control programmes in place to ensure they use non-GM maize.  Grain is grown under contract from seed known to be non-GM. Checks are carried out throughout the chain and systems are audited by independent organisations.

Mycotoxins
Mycotoxins are toxins which can be produced by infections such as mildew and fusarium affecting growing plants. Euromaisiers is following this development through the realization of European surveys, and is also frequently allowing its members to exchange information and experience on possibilities of reducing mycotoxins during growing and storage of maize.

Speeches from main events:

• CAP / Biofuel / WTO - Consequences for Cereals
• Maize GMO Traceability
• Buffaria's presentation
• Presentation EFSA